Ozanimod Capsules bulk supplier for pharma manufacturers

Ozanimod Capsules 0.92 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 0.92 mg

Reference Brands: Zeposia(US & EU)

Ozanimod is a selective S1P receptor modulator that inhibits lymphocyte migration, reducing inflammation in autoimmune diseases. It decreases relapse rates and disease activity in multiple sclerosis and ulcerative colitis. Benefits include oral administration, targeted immune regulation, fewer relapses, and improved quality of life for patients with chronic inflammatory conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ozanimod capsules, marketed as Zeposia, are approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis and ulcerative colitis. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing processes, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional standards for safety and manufacturing.

Ozanimod Capsules — third party manufacturing & bulk supply

Ozanimod Capsules 0.92 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ozanimod Capsules is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ozanimod Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ozanimod Capsules →

Back to Listing

Frequently Asked Questions

Ozanimod Capsules is listed as Capsules in 0.92 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ozanimod Capsules is referenced against Zeposia(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.